The American Journal of Managed Care

Detection and Management of Autoimmune Disease–Associated Interstitial Lung Diseases

Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...
ascopubs.org

Comparison between diameters of the whole nodule and solid area and the proportion of GGO in the tumor shadow on HRCT in predicting less-invasive lung cancer and recurrence ...

Favorable outcomes with chemoradiation and surgery for locally advanced non-small cell lung cancer: The BC Cancer Agency Vancouver experience. Vorinostat (V) intratumoral levels and biomarker response ...
MedPage Today

Hope Rugo, MD, on Interstitial Lung Disease in Patients With Metastatic HER2+ Breast Cancer Receiving T-DXd

A team of experts offered guidance for detecting and managing interstitial lung disease (ILD) in patients with HER2+ metastatic breast cancer treated with trastuzumab deruxtecan (T-DXd). A recent ...
Healio

New ACR SSc-ILD guidelines warn against glucocorticoids as first-line therapy

Please provide your email address to receive an email when new articles are posted on . Newly announced ACR guidelines recommend against glucocorticoids as first-line therapy for interstitial lung ...
Business Wire

Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced ...
The American Journal of Managed Care

Case Report Shows Positive Outcome With Belimumab for CTD-Associated Interstitial Lung Disease

The patient experienced lasting improvement when belimumab was added to her regimen after 2 years. A newly published case report showed Benlysta (belimumab) led to significant improvement in a patient ...